Back to Article
Lifecycle Management as a Roadmap to the Tobacco Endgame
World Journal of Clinical Medicine Research
| Vol 5, Issue 1
Table 1. Views and Viewpoints of the U.S. TobaccoControl Enterprise Using Zachman Interrogatives
| Lifecycle Phase | What (Data / Elements / Products) | How (Processes / Functions) | Where (Locations / Networks) | Who (Stakeholders / Actors) | When (Timeframes / Events) | Why (Goals / Motivations) |
| 1. Conception & Initiation | Epidemiological data, mortality statistics, cost-of-smoking studies, FCTC provisions, draft mission statement | Situational analysis, stakeholder mapping, advocacy planning | Federal policy circles (Congress, HHS), state health departments, public health summits | CDC Office on Smoking and Health, FDA CTP, Surgeon General, advocacy NGOs, tribal health leaders | Initial policy momentum periods, post-Surgeon General reports, pre-election cycles | Build mandate for tobacco control, align with WHO FCTC, secure funding and political commitment |
| 2. Policy & System Design | Draft legislation, regulatory frameworks, taxation policy drafts, organizational charts, performance metric templates | Legislative drafting, regulatory impact analysis, organizational design, budget allocation | Capitol Hill, state legislatures, federal agencies, state DOHs | Federal lawmakers, state legislators, public health lawyers, economic analysts, advocacy coalitions | Legislative sessions, budget cycles, FCTC reporting deadlines | Create enforceable, evidence-based laws and structures for tobacco control |
| 3. Implementation & Operation | Public campaign materials, Quitline infrastructure, NRT stock, inspection reports, compliance databases | Campaign deployment, cessation service delivery, retailer inspections, tax collection enforcement | Community health centers, schools, retail outlets, enforcement field offices | Public health educators, Quitline staff, enforcement officers, local NGOs | Annual public health campaign launches, quarterly compliance sweeps, continuous cessation service availability | Reduce smoking initiation, support quitting, ensure compliance with laws |
| 4. Evaluation & Adaptation | Surveillance datasets, program evaluation reports, illicit trade detection data, vaping prevalence surveys | Data analysis, policy review, stakeholder feedback collection, regulatory adjustment | National data repositories, research institutions, policy workshops | Epidemiologists, academic researchers, policymakers, advocacy leaders | Annual CDC surveys (e.g., NHIS, YRBSS), biennial program evaluations | Improve program effectiveness, respond to emerging products and threats |
| 5. Consolidation & Endgame Transition | Endgame policy packages (smokefree generation law, nicotine reduction regs, sinking lid supply quotas), cross-border enforcement agreements | Intensive cessation targeting, final supply reduction, global coordination | National enforcement hubs, customs checkpoints, international treaty meetings | Federal agencies (FDA, CBP), WHO FCTC Secretariat, neighboring country regulators | Final push period before prevalence <5%, synchronized international enforcement | Eliminate commercial tobacco use, prevent cross-border leakage |
| 6. Sustainment / Sunset | Post-endgame monitoring systems, cultural norm education materials, illicit trade intelligence systems | Long-term surveillance, preventive education, resource reallocation to other public health areas | Local community health networks, schools, customs & border patrol | Sustained public health teams, community educators, law enforcement | Continuous post-endgame monitoring cycles | Prevent relapse, maintain tobacco-free norms, safeguard public health gains |